Urban Health Weekly

Charlotte Owens, MD, FACOG, Head of Medical Affairs and Outcome Research at Organon, discusses unplanned pregnancy and contraceptive deserts and the role of Organon's community-led initiative, Her Plan is Her Power, in addressing them.

Gillian Barclay, Senior Vice President of Global Public Health and Scientific Affairs at Colgate-Palmolive, discusses the critical connection between oral health and overall health, especially among children, and methods to improve oral health education around the world.

Andrew Hertler, MD, talks about the importance of prophylactic mastectomy for individuals carrying high-risk BRCA1, BRCA2, and other deleterious gene mutations.

Adrelia Allen, PharmD, Executive Director of Clinical Trial Patient Diversity at Merck, discusses the urgent push for diverse research participation. Dr. Allen draws on her nearly 30 years of experience in the pharmaceutical field to explain the importance of ensuring clinical research accurately reflects patient populations, Merck’s strategies to promote diversity in clinical trials, and what drives her dedication to the cause.

Andrew Hertler, MD, talks about the updated pancreatic cancer screening guidelines that include individuals carrying the BRCA 1 & BRCA 2 gene mutations, pancreatic cancer prevalence, and the importance of early detection.

Nicole Eggert on Breast Cancer Diagnosis and Being a Single Mother; Microplastics Found in Bottled Water; Desmoid Tumor Survivor Branee tells her story.

Dr. Joe Kimura, CMO of Somatus, talks about the ways that value-based care better serves marginalized people living with chronic kidney disease and the Validation Institute’s Evaluation of Somatus’ Transitions of Care Program.

Maimah Karmo, founder and CEO of Tigerlily Foundation, discusses her cancer journey, Tigerlily Foundation’s partnership with GSK, patient advocacy, Living Legacy, and Pharma accountability in ensuring breast cancer clinical trial access to underrepresented communities.